Comparison of procalcitonin, sCD14 and interleukin-6 values in septic patients

Clinical Chemistry and Laboratory Medicine : CCLM
W HerrmannI Marzi

Abstract

The aim of the study was to investigate whether procalcitonin, soluble CD14 and interleukin-6 show advantages in predicting the outcome and specificity for bacterial infection in patients with sepsis in comparison to common C-reactive protein measurement. Laboratory parameters were measured in plasma of patients during 14 days following the diagnosis of sepsis. Patients fulfilling the ACCP/SCCM criteria for sepsis were admitted to an intensive care unit (n=35). Procalcitonin was measured with an immunoluminometric assay, and soluble CD14 and interleukin-6 were analysed by ELISA. C-reactive protein was determined nephelometrically. Measurements were performed on days 0, 1, 2, 3, 4, 7 and 14. Separating the patients into survivors (n=22) and non-survivors (n=13), it was demonstrated that non-survivors mostly exhibited, after the day of admission, increasing procalcitonin concentrations which peaked around days three and four. In contrast, the procalcitonin concentrations of survivors fell continuously to the value of 2.1 ng/ml which was reported to be important for patients prognosis. The difference between procalcitonin median values of survivors (n=22) and non-survivors (n=13) attained the level of statistical significance on d...Continue Reading

References

Jan 1, 1977·Nephron·O L SilvaC F Moore
Apr 1, 1975·The Journal of Clinical Endocrinology and Metabolism·D D Canale, R K Donabedian
Jan 1, 1992·Research in Immunology·C SchüttC Krüger
Sep 1, 1992·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E S NylenK L Becker
Mar 1, 1992·European Journal of Clinical Investigation·V GrossJ Schölmerich
Feb 13, 1984·FEBS Letters·J M Le MoullecM S Moukhtar
Apr 1, 1995·The Surgical Clinics of North America·F A Moore, E E Moore
Apr 1, 1996·The Journal of Pediatrics·D GendrelC Bohuon
Mar 1, 1996·European Journal of Clinical Investigation·Y M YaoZ Y Sheng
Feb 1, 1997·Acta Paediatrica·G MonneretJ Bienvenu
Jul 1, 1997·The Journal of Infection·Y GérardP Wattre
Apr 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ChiesaL Pacifico
Jul 22, 1998·The American Journal of Gastroenterology·F M BrunkhorstR Brunkhorst

❮ Previous
Next ❯

Citations

Dec 25, 2012·International Journal of Legal Medicine·Cristian PalmierePatrice Mangin
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Liliana SimonJacques Lacroix
Feb 28, 2003·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·J EspinozaB H Yoon
May 31, 2008·The Journal of Physiology·Ole Hartvig MortensenBente Klarlund Pedersen
Dec 9, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Urszula Zielińska-BorkowskaTomasz Skirecki
Dec 5, 2008·Journal of Intensive Care Medicine·M J Ruiz-AlvarezI Arribas
May 11, 2002·Critical Care Medicine·Konrad ReinhartMichael Meisner
May 17, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Juan Casado-FloresMonserrat Nieto
Jun 5, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Valeria SargentiniAlessandra Bachetoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.